|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.95 CNY | -1.24% |
|
-8.79% | -14.47% |
| 05-15 | Hengrui Pharma Gets China Approval for Lymphoma Drug Trial | MT |
| 05-15 | Hengrui Pharma Gets China Nod for Atopic Dermatitis Drug Trial | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.24% | -8.79% | -9.57% | -12.50% | -14.47% | -6.43% | +3.70% | -26.96% | +254.59% | 49.68B | |
| -0.25% | +0.31% | +10.76% | +0.93% | -5.19% | +36.39% | +130.32% | +410.63% | +1,261.94% | 909B | |
| -0.30% | -0.48% | -0.59% | -5.43% | +10.81% | +49.24% | +44.31% | +34.05% | +103.59% | 552B | |
| -0.68% | +1.82% | +4.22% | -5.56% | -7.09% | +14.85% | +46.30% | +81.28% | +255.67% | 375B | |
| -0.23% | +2.53% | +2.24% | -10.79% | -0.03% | +24.56% | +13.82% | +6.53% | +32.78% | 332B | |
| -0.49% | +1.11% | -4.59% | -9.46% | +0.74% | +32.41% | +15.42% | +70.77% | +256.16% | 291B | |
| +0.08% | +1.68% | +2.19% | -7.30% | +8.25% | +26.54% | +30.03% | +49.61% | +54.08% | 287B | |
| -1.09% | -0.40% | -3.50% | -7.57% | +7.35% | +44.93% | -2.16% | +41.85% | +105.04% | 279B | |
| -0.31% | +0.54% | +16.37% | +14.38% | -11.59% | -37.02% | -51.25% | +15.76% | +61.59% | 199B | |
| +0.25% | -1.45% | -5.31% | -11.52% | +1.30% | +20.57% | +48.41% | +31.61% | +120.78% | 179B | |
| +0.15% | -1.77% | -3.81% | -13.68% | +6.48% | +19.78% | +65.76% | +88.45% | +58.14% | 162B | |
| +0.51% | -0.65% | -6.29% | -3.23% | +3.57% | +9.65% | -29.86% | -35.72% | -23.56% | 147B | |
| +0.39% | +3.81% | -1.00% | -3.49% | +8.53% | +22.29% | -11.09% | -12.63% | -17.28% | 120B | |
| -0.89% | -4.99% | -1.99% | -9.74% | -5.06% | -3.74% | +25.97% | +98.72% | +408.19% | 109B | |
| +1.02% | +5.73% | -4.42% | -4.11% | -6.38% | -17.40% | -22.79% | -12.23% | +10.31% | 107B | |
| +0.13% | +1.55% | -8.67% | -13.80% | +4.22% | +32.97% | +33.36% | +12.27% | +5.79% | 102B | |
| -0.80% | -3.21% | -9.87% | -22.42% | -4.94% | +6.32% | +111.73% | +87.20% | +514.59% | 81.86B | |
| -1.43% | -1.45% | -5.61% | -10.97% | +7.14% | +25.09% | +13.77% | +35.78% | +9.49% | 52.28B | |
| -1.20% | +1.73% | -2.83% | -9.25% | +4.94% | +63.78% | -27.97% | -30.63% | -53.99% | 44.82B | |
| +0.15% | +3.83% | -3.01% | -16.58% | -8.83% | -17.40% | +0.69% | - | - | 40.65B | |
| Average | -0.25% | +0.60% | -1.76% | -8.11% | -0.01% | +17.37% | +21.92% | +49.81% | +179.89% | 220.97B | |
| Weighted average by Cap. | -0.06% | +0.86% | +1.66% | -5.46% | +0.46% | +25.33% | +43.76% | +115.21% | +357.83% |
- Stock Market
- Equities
- 600276 Stock
- Sector Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition